| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,860 |
15,119 |
$2.86M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,030 |
11,554 |
$2.11M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,357 |
8,927 |
$1.57M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
21,264 |
6,094 |
$1.39M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,421 |
4,191 |
$1.25M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,306 |
2,274 |
$701K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
6,110 |
5,961 |
$659K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,164 |
2,127 |
$646K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
18,780 |
5,414 |
$558K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,146 |
1,803 |
$482K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,455 |
2,399 |
$447K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
526 |
525 |
$382K |
| 80053 |
Comprehensive metabolic panel |
13,560 |
12,301 |
$318K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,545 |
1,482 |
$310K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
606 |
596 |
$184K |
| 36415 |
Collection of venous blood by venipuncture |
18,650 |
9,491 |
$171K |
| 97161 |
|
1,371 |
1,365 |
$162K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
184 |
184 |
$156K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
454 |
435 |
$81K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
343 |
341 |
$72K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,780 |
1,748 |
$65K |
| 59025 |
Fetal non-stress test |
253 |
201 |
$61K |
| 80076 |
|
2,542 |
2,450 |
$60K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,167 |
2,107 |
$56K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
883 |
883 |
$55K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,725 |
3,477 |
$55K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,429 |
1,412 |
$55K |
| 86850 |
|
1,239 |
1,202 |
$54K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,308 |
1,288 |
$50K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
53 |
53 |
$49K |
| 97162 |
|
349 |
344 |
$48K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
989 |
976 |
$45K |
| 88342 |
|
659 |
656 |
$42K |
| 76830 |
Ultrasound, transvaginal |
501 |
492 |
$41K |
| 86900 |
|
1,690 |
1,260 |
$40K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
154 |
152 |
$38K |
| 12001 |
|
73 |
73 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,509 |
2,320 |
$37K |
| 86901 |
|
1,363 |
953 |
$36K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
69 |
68 |
$35K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
838 |
825 |
$31K |
| 76801 |
|
252 |
220 |
$26K |
| 85610 |
|
7,531 |
7,089 |
$24K |
| 93971 |
|
121 |
120 |
$18K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,813 |
6,341 |
$18K |
| 83880 |
|
612 |
590 |
$18K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
367 |
354 |
$16K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
837 |
825 |
$16K |
| 76641 |
|
578 |
576 |
$14K |
| 29125 |
|
52 |
52 |
$13K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,539 |
4,154 |
$13K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
320 |
147 |
$12K |
| 81025 |
|
3,566 |
3,479 |
$12K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
49 |
49 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,346 |
10,127 |
$8K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
24 |
24 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
34 |
34 |
$6K |
| 96368 |
|
99 |
92 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
1,053 |
1,043 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,376 |
4,816 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
5,076 |
4,869 |
$5K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
145 |
141 |
$5K |
| 90715 |
|
167 |
167 |
$4K |
| 93017 |
|
33 |
32 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
44 |
44 |
$4K |
| 73030 |
|
449 |
431 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
639 |
618 |
$4K |
| 73564 |
|
235 |
235 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,176 |
2,842 |
$3K |
| 82803 |
|
112 |
98 |
$3K |
| 29530 |
|
13 |
13 |
$3K |
| 29515 |
|
12 |
12 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
477 |
477 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,469 |
1,420 |
$3K |
| 84484 |
|
4,134 |
3,461 |
$3K |
| 90714 |
|
100 |
100 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
56 |
55 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
95 |
47 |
$2K |
| 84439 |
|
386 |
376 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
12 |
12 |
$2K |
| 85730 |
|
2,423 |
2,320 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
126 |
123 |
$2K |
| 73610 |
|
524 |
510 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
239 |
238 |
$2K |
| 88304 |
|
28 |
28 |
$2K |
| 77065 |
Tomosynthesis, mammo |
29 |
27 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
13 |
13 |
$2K |
| 73130 |
|
235 |
234 |
$2K |
| 85055 |
|
43 |
38 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,231 |
1,123 |
$2K |
| 72170 |
|
209 |
208 |
$1K |
| 73630 |
|
379 |
373 |
$1K |
| 83605 |
|
1,229 |
1,129 |
$1K |
| 81001 |
|
4,772 |
4,544 |
$1K |
| 83735 |
|
2,937 |
2,677 |
$1K |
| 80061 |
Lipid panel |
171 |
170 |
$1K |
| 82728 |
|
99 |
97 |
$1K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
70 |
69 |
$1K |
| 84703 |
|
2,129 |
2,046 |
$1K |
| 72100 |
|
169 |
168 |
$1K |
| 36591 |
|
35 |
35 |
$951.91 |
| 83690 |
|
3,642 |
3,399 |
$940.05 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
13 |
$936.73 |
| 82248 |
|
1,382 |
1,259 |
$908.95 |
| 82150 |
|
1,514 |
1,420 |
$892.36 |
| 83615 |
|
222 |
189 |
$872.62 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
259 |
248 |
$854.73 |
| 76819 |
Fetal biophysical profile; without non-stress testing |
16 |
12 |
$848.30 |
| 77080 |
|
12 |
12 |
$806.54 |
| 76536 |
|
37 |
37 |
$777.00 |
| 85027 |
|
821 |
764 |
$763.67 |
| J7050 |
Infusion, normal saline solution, 250 cc |
533 |
411 |
$718.55 |
| 84702 |
|
544 |
482 |
$690.80 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,214 |
1,177 |
$666.64 |
| 72114 |
|
29 |
29 |
$626.03 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
991 |
900 |
$585.21 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,671 |
3,366 |
$546.46 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
26 |
12 |
$538.46 |
| 73110 |
|
97 |
92 |
$538.09 |
| 36416 |
|
35 |
33 |
$479.97 |
| 85379 |
|
1,070 |
1,046 |
$474.31 |
| 83540 |
|
95 |
92 |
$471.12 |
| 82962 |
|
992 |
577 |
$431.11 |
| 83550 |
|
84 |
81 |
$411.28 |
| 87081 |
|
1,069 |
1,049 |
$396.27 |
| 96376 |
|
409 |
402 |
$378.18 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,487 |
1,405 |
$360.71 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
111 |
96 |
$355.47 |
| 73562 |
|
115 |
114 |
$329.74 |
| 72110 |
|
12 |
12 |
$312.00 |
| 82378 |
|
16 |
15 |
$293.27 |
| 81003 |
|
1,074 |
1,045 |
$272.08 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
116 |
112 |
$261.90 |
| 87040 |
|
1,014 |
594 |
$259.52 |
| 86300 |
|
13 |
12 |
$251.78 |
| 82948 |
|
504 |
362 |
$155.54 |
| 86140 |
|
101 |
99 |
$151.96 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
511 |
468 |
$107.76 |
| 85652 |
|
176 |
168 |
$83.44 |
| 87070 |
|
770 |
759 |
$80.18 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
70 |
63 |
$61.37 |
| J2704 |
Injection, propofol, 10 mg |
1,375 |
1,261 |
$52.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,026 |
2,839 |
$50.25 |
| 73502 |
|
12 |
12 |
$44.88 |
| 84100 |
|
120 |
109 |
$39.47 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
24 |
12 |
$33.55 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
177 |
174 |
$29.78 |
| 80299 |
|
73 |
72 |
$29.61 |
| 74018 |
|
31 |
28 |
$28.00 |
| 80320 |
|
225 |
214 |
$25.25 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
18 |
12 |
$24.58 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,227 |
1,198 |
$19.31 |
| 86618 |
|
45 |
45 |
$18.83 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
231 |
217 |
$15.79 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
271 |
233 |
$14.19 |
| 87430 |
|
586 |
576 |
$10.40 |
| 73560 |
|
74 |
71 |
$10.10 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
171 |
141 |
$9.73 |
| 87077 |
|
32 |
32 |
$9.70 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
674 |
651 |
$7.19 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,051 |
1,015 |
$6.95 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
189 |
177 |
$6.93 |
| 87186 |
|
32 |
32 |
$6.59 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
656 |
614 |
$5.85 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
769 |
710 |
$4.81 |
| J2060 |
Injection, lorazepam, 2 mg |
14 |
12 |
$1.75 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
76 |
74 |
$0.28 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
392 |
378 |
$0.08 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
13 |
12 |
$0.00 |
| 99080 |
|
303 |
55 |
$0.00 |
| 80179 |
|
14 |
14 |
$0.00 |
| 86753 |
|
24 |
12 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
182 |
162 |
$0.00 |
| 82550 |
|
66 |
63 |
$0.00 |
| 87147 |
|
16 |
13 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
64 |
64 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
74 |
70 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
38 |
38 |
$0.00 |
| 86617 |
|
24 |
14 |
$0.00 |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
13 |
13 |
$0.00 |
| 87205 |
|
13 |
13 |
$0.00 |